Category: Moneyball Picks
-
I asked Twitter what tickers I should be writing about: Twitter had 35 ideas… here’s 6 of them
Ever get the feeling, looking at your watchlist, that you’re seeing the same thing over and over? That maybe there’s interesting stuff out there you just haven’t heard about yet? I put a simple question to Twitter today: “Give me a ticker symbol you think I should be writing about (limit one per person), three…
-
Fair trade: Green Organic Dutchman (TGOD.T) does the hard, sensible things required to reset
Because this story is about The Green Organic Dutchman (TGOD.T) and cannabis investors bear grudges, the vast majority of people reading it will already be saying the words, “Fuck Parry, you’ll pump anything for money.” So let’s get some things out of the way before we start. 1) TGOD isn’t paying for this story, and…
-
The Inflection Point: It’s now or never for Plus Products (PLUS.C)
When weed legalized in Canada, I wasn’t a consumer participant. Smoking up has never been my jam. I know some like the ritual of it all, but I see having to prep and grind and smoke as being similar to driving stick – I mean, why not also stop your car by cutting two holes…
-
The case that Supreme Cannabis (FIRE.T) is about to shake its demons and go on a rip
Supreme Cannabis (FIRE.T) got a new President and CEO today in Beena Goldenberg, former chief executive officer of Hain-Celestial Canada, and a bona fide pro in the natural and plant-based consumer packaged goods business. This would appear to be a good hire for a company that already has a great reputation for quality products in…
-
Nexus Gold (NXS.V) – finally – actually – miraculously – lifts on news, up 50%
At Equity.Guru, we’ve been tight with Nexus Gold (NXS.V) boss Alex Klenman for years. he’s been through it with Nexus, from former CEOs selling off his stock in secret, filing their insde trading docs a year late, to stock promoters demanding money and then, upon being refused, crashing the stock, to dark pool shenanigans and…
-
Falcon Gold (FG.V), up 60% on new properties, drills turning, and the novel tactic of ‘doing work’
Karim Rayani is a deal guy from way back, a non-stop money raiser, deal maker, handshaker and groover/shaker. If you needed a guy to invest in a biotech deal, Karim would go find him. If you needed some dough to kickstart a palladium mine, Karim will have a guy who knows a guy. And if…
-
Revive Therapeutics (RVV.C) warned about overhype, but up 26% on clinical trial news
Oddball pharmaceutical player Revive Therapeutics (RVV.C) found itself on the back end of a warning by the BCSC this week, that certain German players in the smallcap promotion space had over-hyped the mushroom/cannabis/biotech deal and promised big wins inappropriately for anyone who invested. As a marketing partner of Revive, I got a few panicky texts…
-
Heritage Cannabis (CANN.C) loses $2.3 million in Q4, finds extra year of runway as revenues kick in
A quick scan of headlines today would tell a harrowing story that Heritage Cannabis (CANN.C) was in big trouble and had lost $13 million and pandemonium had broken loose, and dogs and cats were going to be living together any time now. That’s because the company led their Q4 financials news release today with their…